Woodward Specialty LLC
Records under this name other than the patents Woodward Specialty LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Back to Woodward Specialty LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,889,685 | Method for Treating a Sleep Diorder with Eszopiclone Maleate Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,877,755 | Dopamine-Agonist Combination Therapy For Improving Sleep Quality Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 7,465,729 | Methods of Treatment of Menopause and Perimenopause Using Eszopiclone Term ended Term ended Apr 27, 2026 · High confidence | Term ended | Term ended Apr 27, 2026 | High confidence |
| US 11,278,492 | Intranasal Delivery of Olanzapine by Precision Olfactory Device Lapsed on the fee record Ended Mar 22, 2026 · High confidence | Lapsed on the fee record | Ended Mar 22, 2026 | High confidence |
| US 8,497,268 | Method for Providing Blook Levels of Eszopiclone with Maleate Salts Lapsed on the fee record Ended Jul 30, 2025 · High confidence | Lapsed on the fee record | Ended Jul 30, 2025 | High confidence |
| US 7,776,858 | Methods of Treatment of Chronic Pain Using Eszopiclone Term ended Term ended Apr 5, 2025 · High confidence | Term ended | Term ended Apr 5, 2025 | High confidence |
| US 7,893,100 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Term ended Term ended Dec 30, 2024 · USPTO record | Term ended | Term ended Dec 30, 2024 | USPTO record |
| US 8,329,950 | Process for Preparation of Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1NAPTHALENAMINE Lapsed on the fee record Ended Dec 11, 2024 · Medium confidence | Lapsed on the fee record | Ended Dec 11, 2024 | Medium confidence |
| US 8,268,832 | Maleate Salts of 6-(5-Chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine Lapsed on the fee record Ended Sep 18, 2024 · Medium confidence | Lapsed on the fee record | Ended Sep 18, 2024 | Medium confidence |
| US 7,189,715 | Compositions comprising zopiclone derivatives and methods of making and using the same Term ended Term ended Sep 8, 2024 · USPTO record | Term ended | Term ended Sep 8, 2024 | USPTO record |